BAC
Bank of America Corporation
BAC has a slight edge over WAL overall, supported by stronger fundamentals and lower modeled downside.
WAL
Western Alliance Bancorporation
WAL offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
WAL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
WAL's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like WAL.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over WAL in the historical PE scenario, which offers more potential upside but is not a forecast.
WAL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.2x | $65.13 | -12% |
| Forward | 7.2x | $74.39 | — |
| Current | 8.2x | $74.39 | — |
| Fair | 9.4x | $84.88 | +14% |
| Expensive | 13x | $118 | +58% |
Historical ranges are pointers, not guarantees.
WAL's PE is in its cheap range at 8.2x. If earnings grow as analysts expect, today's price would be 7.2x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
WAL Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for WAL, with profitability improving. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over WAL on earnings, with stronger typical year-over-year growth.
WAL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.33 | +14% |
| Q3 2026 | $9.05 | +12% |
| Q2 2026 | $8.88 | +17% |
| Q1 2026 | $8.59 | +18% |
| Q4 2025 | $8.73 | +23% |
| Q3 2025 | $8.08 | +25% |
| Q2 2025 | $7.60 | +14% |
| Q1 2025 | $7.28 | +6.1% |
| Q4 2024 | $7.09 | +8.4% |
WAL's earnings per share have climbed steadily: $9.05 over the past year, up 12% from the year before, and higher year over year for eight quarters in a row.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
WAL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1B | +8.1% |
| Q2 2026 | $995.7M | +18% |
| Q1 2026 | $1B | +31% |
| Q4 2025 | $980.9M | +17% |
| Q3 2025 | $938.2M | +14% |
| Q2 2025 | $845.9M | +9.6% |
| Q1 2025 | $778M | +6.8% |
| Q4 2024 | $838.4M | +23% |
WAL has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 33% | 0 points |
| Q2 2026 | 33% | -1.1 points |
| Q1 2026 | 23% | -9 points |
| Q4 2025 | 36% | +5.3 points |
| Q3 2025 | 33% | +2.8 points |
| Q2 2025 | 34% | +2.3 points |
| Q1 2025 | 32% | -0.1 points |
| Q4 2024 | 31% | 0 points |
WAL has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over WAL on cash generation, producing positive trailing cash flow while its opponent burns cash.
WAL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $769.9M | +$1.4B |
| Q2 2026 | -$356.1M | +$1.6M |
| Q1 2026 | -$507.2M | +$1.1B |
| Q4 2025 | -$69.8M | +$551.9M |
| Q3 2025 | -$597.4M | +$470.6M |
| Q2 2025 | -$357.7M | +$388.1M |
| Q1 2025 | -$1.7B | -$1.3B |
| Q4 2024 | -$621.7M | -282% |
WAL's free cash flow was −$163M over the past year, against −$3.2B the year before. Free cash flow isn't a meaningful measure for financial services companies like WAL.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over WAL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
WAL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -200K shares |
| 1 year | -1.8% | -2M shares |
| 3 years | -0.6% | -700K shares |
| 5 years | +3.8% | +3.9M shares |
| Available history | +4.5% | +4.7M shares |
WAL has 108M diluted shares, down 1.8% from a year ago, with $203M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $93.1M |
| Q2 2026 | $2.3M |
| Q1 2026 | $50.3M |
| Q4 2025 | $57.5M |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
WAL spent $203M buying back its own shares over the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
WAL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.8x | Elevated |
| Q2 2026 | 4.3x | High |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.6x | Elevated |
| Q3 2025 | 2.8x | Moderate |
| Q2 2025 | 4.9x | High |
| Q1 2025 | 3.4x | Elevated |
| Q4 2024 | 4.8x | High |
WAL has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
WAL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.8 | Neutral |
| Stochastic | 30.1 | Neutral |
WAL's weekly RSI is 41 (neutral) and its Stochastic is 30 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
WAL PE vs Financial Services Sector
| Metric | WAL | Sector median | Relative |
|---|---|---|---|
| PE | 8.2x | 13x | 37% below |
| PE % | 26 | 63 | 37 pts below |
WAL has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
WAL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $75.6 | 1.7% below |
| 20 week MA | $78.7 | 5.5% below |
| 50 week MA | $80.5 | 7.6% below |
| 100 week MA | $80.3 | 7.4% below |
| 200 week MA | $70.1 | 6.2% above |
WAL has fallen below most of its moving averages, though it's still 6.2% above its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over WAL on returns for 2026, with the stronger performance.
WAL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $57.0 | $59.9 | +5.1% |
| 2021 | $59.9 | $105.7 | +76% |
| 2022 | $105.7 | $58.1 | -45% |
| 2023 | $58.1 | $65.8 | +13% |
| 2024 | $65.8 | $83.7 | +27% |
| 2025 | $83.7 | $86.6 | +3.4% |
| 2026 YTD | $86.6 | $74.4 | -14% |
WAL has finished higher in five of the last six years. It's down 14% so far in 2026.